Package 0409-1704-01

{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "e7c31651-e301-43f9-bc81-e0fd5dcb828c", "openfda": {"nui": ["N0000175604", "N0000175075"], "unii": ["69G8BD63PP"], "rxcui": ["2601542", "2601544"], "spl_set_id": ["9fdf6169-699f-40eb-bda1-760253062b3c"], "pharm_class_epc": ["Proteasome Inhibitor [EPC]"], "pharm_class_moa": ["Proteasome Inhibitors [MoA]"], "manufacturer_name": ["Hospira, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0409-1704-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE", "package_ndc": "0409-1704-01", "marketing_start_date": "20220516"}], "brand_name": "BORTEZOMIB", "product_id": "0409-1704_e7c31651-e301-43f9-bc81-e0fd5dcb828c", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Proteasome Inhibitor [EPC]", "Proteasome Inhibitors [MoA]"], "product_ndc": "0409-1704", "generic_name": "BORTEZOMIB", "labeler_name": "Hospira, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BORTEZOMIB", "active_ingredients": [{"name": "BORTEZOMIB", "strength": "1 mg/1"}], "application_number": "NDA209191", "marketing_category": "NDA", "marketing_start_date": "20220516", "listing_expiration_date": "20261231"}